Home/Filings/4/0001185945-16-000002
4//SEC Filing

TENAX THERAPEUTICS, INC. 4

Accession 0001185945-16-000002

$TENXCIK 0000034956operating

Filed

Oct 19, 8:00 PM ET

Accepted

Oct 20, 10:05 AM ET

Size

4.7 KB

Accession

0001185945-16-000002

Insider Transaction Report

Form 4
Period: 2016-05-01
Jebsen Michael B
Chief Financial Officer
Transactions
  • Award

    common stock

    2016-05-01$2.72/sh+430$1,17068,409 total

Issuer

TENAX THERAPEUTICS, INC.

CIK 0000034956

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0000034956

Filing Metadata

Form type
4
Filed
Oct 19, 8:00 PM ET
Accepted
Oct 20, 10:05 AM ET
Size
4.7 KB